Your browser doesn't support javascript.
loading
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
Kandzari, David E; Smits, Pieter C; Love, Michael P; Ben-Yehuda, Ori; Banai, Shmuel; Robinson, Simon D; Jonas, Michael; Kornowski, Ran; Bagur, Rodrigo; Iniguez, Andres; Danenberg, Haim; Feldman, Robert; Jauhar, Rajiv; Chandna, Harish; Parikh, Manish; Perlman, Gidon Y; Balcells, Mercedes; Markham, Peter; Ozan, Melek Ozgu; Genereux, Philippe; Edelman, Elazer R; Leon, Martin B; Stone, Gregg W.
Afiliação
  • Kandzari DE; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Smits PC; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Love MP; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Ben-Yehuda O; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Banai S; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Robinson SD; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Jonas M; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Kornowski R; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Bagur R; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Iniguez A; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Danenberg H; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Feldman R; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Jauhar R; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Chandna H; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Parikh M; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Perlman GY; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Balcells M; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Markham P; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Ozan MO; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Genereux P; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Edelman ER; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Leon MB; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
  • Stone GW; From Piedmont Heart Institute, Atlanta, GA (D.E.K.); Maasstad Hospital, Rotterdam, The Netherlands (P.C.S.); Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia (M.P.L.); Columbia University Medical Center and the Cardiovascular Research Foundation, New York (O.B.-Y., M.P., M.O.O., P.G.,
Circulation ; 136(14): 1304-1314, 2017 Oct 03.
Article em En | MEDLINE | ID: mdl-28794001
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Sirolimo / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Papua-Nova Guiné
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Sirolimo / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Papua-Nova Guiné